Document is current

Article History

Received: 26 August 2025

Accepted: 8 March 2026

First Online: 22 April 2026

Declarations

:

: Approval was given by the Icahn School of Medicine at Mount Sinai’s Program for the Protection of Human Subjects (PPHS). Informed consent was waived by the internal review board due to the retrospective nature of the study. PPHS. Study-21-01490.

: Waived by IRB.

: D.J.: No relevant relationships. F.R.: No relevant relationships. K.Y.: No relevant relationships. E.O.: No relevant relationships. M.T.: No relevant relationships. M.B.: No relevant relationships. A.S.: No relevant relationships. J.F.: No relevant relationships. O.B.: No relevant relationships. H.v.B.: Employee of Siemens Healthineers but not involved in any data handling or analysis. Owns stock in Siemens AG, Siemens Healthineers AG, and Royal Philips R.G.: Employee of Siemens Healthineers but not involved in any data handling or analysis. Owns stock in Siemens Healthineers. A.K.T.: Site-PI on sponsored clinical trials from Kite Pharma Inc., Lumicell, Inc., Dendron Pharmaceuticals, LLC, Oncovir Inc., Blue Earth Diagnostics Ltd., RhoVac ApS., Bayer HealthCare Pharmaceuticals Inc., Janssen Research and Development, LLC. Has served as an unpaid consultant to Roivant Biosciences and as an advisor to Promaxo, where he owns equity. Not involved in data handling or analysis. S.L.: No relevant relationships. B.T.: Research support from Bayer, Takeda, Regeneron, Helio Health, Echosens, Guerbet, and Siemens Healthineers. Consulting services for Bayer, Guerbet, and Ascelia. No fiduciary responsibility with Siemens Healthineers.